"The U.S. Food and Drug Administration today approved Vimizim (elosulfase alfa), the first FDA-approved treatment for Mucopolysaccharidosis Type IVA (Morquio A syndrome). Morquio A syndrome is a rare, autosomal recessive lysosomal storage disease "...
Allergic reactions including anaphylaxis have been reported infrequently following the administration of Sodium Pertechnetate Tc 99m.
Read the Ultra-TechneKow (technetium tc 99m generator for the production of sodium pertechnetate tc 99m injection) Side Effects Center for a complete guide to possible side effects
No information provided.
Last reviewed on RxList: 3/3/2014
This monograph has been modified to include the generic and brand name in many instances.
Additional Ultra-TechneKow Information
Report Problems to the Food and Drug Administration
Find out what women really need.